New heart ablation technique targets hidden drivers of AFib
NCT ID NCT07390175
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new way to treat persistent atrial fibrillation (AFib) by targeting specific high-frequency areas in the heart that may be driving the condition. Researchers will compare this new ablation method to standard treatment in 78 adults with long-lasting AFib or recurrent ventricular fibrillation. The goal is to see if this approach can stop AFib more effectively and safely.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
catheter ablation procedure
What this could lead to
If successful, this could lead to a more effective and safer ablation technique for persistent atrial fibrillation, reducing recurrence and improving quality of life.
What could go wrong
This is an early-stage study with a small number of participants. The new ablation approach may not be more effective than standard treatment and carries typical risks of cardiac ablation, such as bleeding or heart rhythm disturbances.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Clínico San Carlos
RECRUITINGMadrid, Madrid, 28040, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••